Literature DB >> 18569917

The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients.

Paul J Phelan1, Patrick O'Kelly, Joseph J Walshe, Peter J Conlon.   

Abstract

Secondary hyperparathyroidism and abnormal calcium/phosphate balance are common complications of ESRD and significant cardiovascular risk factors. It has also been demonstrated that malnourished dialysis patients have a much higher mortality than well-nourished patients. There is a lack of research looking at combined mortality with altered mineral metabolism and a low serum albumin. Using our renal database, we analyzed outcomes on 1,007 chronic dialysis patients, commencing dialysis between January 1990 and December 2004. The association between median values of serum phosphate, calcium, albumin (between three and six months post-commencement of dialysis), and long-term survival was examined. Cox proportional hazards models were used to determine the combined effects of these variables on patient outcome. The results showed that 18% of patients had serum phosphorous >1.8 mmol/L (5.5 g/dL), and the five-year survival of these patients was 48.4% compared with 58.6% for those with a serum phosphorous <1.8 mmol/L (p = 0.047). For serum albumin, 34.9% had a value <35 g/L, and this group also had a highly significant risk of increased mortality (p < 0.001). When combined with corrected calcium, 40.9% of patients reached all three target levels and had the greatest long-term survival (five-year survival of 62.5% for all three targets reached, compared to 30.7% for 0 or 1 targets reached). Poor control of calcium/phosphorous balance appears to have long-term deleterious effects on patient survival in ESRD patients. This risk of death is increased by poor serum albumin levels reflecting inadequate nutrition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18569917     DOI: 10.1080/08860220801964236

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  8 in total

1.  Relation of serum phosphorus levels to carotid intima-media thickness in asymptomatic young adults (from the Bogalusa Heart Study).

Authors:  Litao Ruan; Wei Chen; Sathanur R Srinivasan; Jihua Xu; Ahmet Toprak; Gerald S Berenson
Journal:  Am J Cardiol       Date:  2010-08-02       Impact factor: 2.778

2.  SOD3 and IL-18 Predict the First Kidney Disease-Related Hospitalization or Death during the One-Year Follow-Up Period in Patients with End-Stage Renal Disease.

Authors:  Yu-Hsien Liu; Yu-Hsuan Chen; Chi-Hua Ko; Chia-Wen Kuo; Chih-Ching Yen; Wei Chen; Kowit-Yu Chong; Chuan-Mu Chen
Journal:  Antioxidants (Basel)       Date:  2022-06-18

3.  Low Parathyroid Hormone Versus Secondary Hyperparathyroidism and Survival in Patients Undergoing Hemodialysis: A Propensity-Matched Analysis.

Authors:  Wang Guo; Huixian Zhang; Yamei Zhang; Hongdong Huang; Wenhu Liu; Zongli Diao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-13       Impact factor: 6.055

4.  Serum albumin and kidney function decline in HIV-infected women.

Authors:  Joshua Lang; Rebecca Scherzer; Phyllis C Tien; Chirag R Parikh; Kathryn Anastos; Michelle M Estrella; Alison G Abraham; Anjali Sharma; Mardge H Cohen; Anthony W Butch; Marek Nowicki; Carl Grunfeld; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2014-07-22       Impact factor: 8.860

5.  Association of serum albumin levels with kidney function decline and incident chronic kidney disease in elders.

Authors:  Joshua Lang; Ronit Katz; Joachim H Ix; Orlando M Gutierrez; Carmen A Peralta; Chirag R Parikh; Suzanne Satterfield; Snezana Petrovic; Prasad Devarajan; Michael Bennett; Linda F Fried; Steven R Cummings; Mark J Sarnak; Michael G Shlipak
Journal:  Nephrol Dial Transplant       Date:  2018-06-01       Impact factor: 5.992

Review 6.  Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease.

Authors:  Denis Fouque; Marc Vervloet; Markus Ketteler
Journal:  Drugs       Date:  2018-08       Impact factor: 9.546

Review 7.  Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis.

Authors:  Jaime L Natoli; Rob Boer; Brian H Nathanson; Ross M Miller; Silvia Chiroli; William G Goodman; Vasily Belozeroff
Journal:  BMC Nephrol       Date:  2013-04-17       Impact factor: 2.388

8.  Improvements in renal replacement therapy practice patterns in estonia.

Authors:  Külli Kõlvald; Ulle Pechter; Merike Luman; Madis Ilmoja; Mai Ots-Rosenberg
Journal:  Nephron Extra       Date:  2014-07-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.